Oxford Provides $15M Senior Credit Facility
Oxford Finance LLC., a specialty finance firm that provides senior debt to life sciences and healthcare services companies based in Alexandria, announced a $15 million round of debt financing for Vitae Pharmaceuticals, a clinical‐stage biopharmaceutical company discovering and developing a portfolio of novel, small molecule compounds that address important disease areas. The senior credit facility was awarded to Vitae from both Oxford and Silicon Valley Bank. The funds will be used to support the progress of Vitae’s drug pipeline, which includes treatments for chronic kidney disease, diabetes, Alzheimer’s disease and atherosclerosis.
“The company has a very promising portfolio of novel, small molecule, best‐inclass compounds, and has a track record of successfully partnering with major pharmaceutical companies to further the progress of its clinical stage assets,“ said Christopher A. Herr,managing director for Oxford Finance. “Oxford is pleased to provide funds to support Vitae’s drug development programs,”
